Drug class
Non-selective beta-adrenergic receptor agonist; bronchodilator (metaproterenol)
Mechanism of action
Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cyclic AMP and causing bronchodilation. It also has beta-1 activity, particularly at higher systemic exposure.
General use cases
- Relief of bronchospasm in asthma and reversible obstructive airway disease in countries where orciprenaline products remain authorised; clinical use and availability are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
